82.7 F
New York
Friday, July 30, 2021

Trump Receives Gilead’s [NASDAQ: GILD] Remdesivir As Treatment For COVID-19 Infection

Must read

Ucommune [NASDAQ: UK] Ink Cooperation Agreement with Beijing Investment Group

Ucommune International Ltd. inked a cooperation agreement with Beijing Investment Group Co., LTD. Beijing Investment is a fully state-owned land developer associated with...

Lion Electric [NYSE: LEV] all Set to Deliver Two Electric Trucks to Green Mountain Power

The Lion Electric Company revealed on Friday that it is preparing to deliver two of its all-electric trucks to Green Mountain Power (GMP)...

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

Gilead Sciences, Inc’s [NASDAQ: GILD] remdesivir has been given to President Donald Trump at Walter Reed National Military Medical Center on Friday.

It has been revealed that the white house doctors have recommended the experimental drug of Gilead to treat the COVID-19 infection of President Donald Trump.

White House Physician Sean Conley has released an update on the health of President Donald Trump. Sean Conley disclosed that President Trump is doing well and he doesn’t require any supplemental oxygen.

But the doctors have chosen the Gilead Sciences’ remdesivir to treat his COVID-19 infection. Trump has received the first dose and he is resting comfortably.

Shares of Gilead Sciences [NASDAQ: GILD] traded down 1.82% as it lost -1.15 during the trading session of Friday. It has a closing price of $62.17. GILD had a trading volume of 7.76 million as compared to the average volume of 8.70 million.

In the past 52-weeks of trading, this company’s share fluctuated between the low range of $60.89 and a high range of $85.97. GILD has moved up 2.10% from its 52-weeks low and moved down -27.68% from its 52-weeks high.

Looking at its profitability, this company has a current ratio of $2.30. GILD market capitalization has remained high, hitting $77.94 billion at the time of writing.

Gilead has committed to combat the spread of coronavirus by increasing the production of antiviral drug remdesivir.

The company has donated 1.5 million vials of Veklury (remdesivir) and provided clinical drug supply at no cost for evaluation as an investigational agent in clinical trials around the world. 

President Donald Trump has revealed on Friday that he and his wife Melania Trump has contracted coronavirus. Trump administration has earlier gave an emergency use authorization to Gilead’s remdesivir after it showed the positive results in treating COVID-19 patients.

More articles

Latest article

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...